| Name | N-(5-Bromo-4-methyl-1,3-thiazol-2-yl)acetamide |
|---|---|
| Synonyms |
N-(5-Brom-4-methyl-thiazol-2-yl)-acetamid
2-Acetamido-5-brom-4-methylthiazol N-(5-Bromo-4-methylthiazol-2-yl)acetamide 5-Brom-2-acetamino-4-methyl-thiazol |
| Molecular Formula | C6H7BrN2OS |
|---|---|
| Molecular Weight | 235.10200 |
| Exact Mass | 233.94600 |
| PSA | 70.23000 |
| LogP | 2.24540 |
| HS Code | 2934100090 |
|---|
|
~%
21478-95-5 |
| Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2003/72557 A1, 2003 ; Location in patent: Page/Page column 41 ; WO 03/072557 A1 |
|
~%
21478-95-5 |
| Literature: Behringer,H.; Kuchinka,K. Justus Liebigs Annalen der Chemie, 1961 , vol. 650, p. 179 - 186 |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |